100 related articles for article (PubMed ID: 22177326)
21. Adverse effects of contrast media: incidence, prevention and management.
Thomsen HS; Bush WH
Drug Saf; 1998 Oct; 19(4):313-24. PubMed ID: 9804445
[TBL] [Abstract][Full Text] [Related]
22. Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment.
Li Y; Wang J
BMC Nephrol; 2024 Apr; 25(1):140. PubMed ID: 38649939
[TBL] [Abstract][Full Text] [Related]
23. Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial.
Jones DA; Beirne AM; Kelham M; Wynne L; Andiapen M; Rathod KS; Parakaw T; Adams J; Learoyd A; Khan K; Godec T; Wright P; Antoniou S; Wragg A; Yaqoob M; Mathur A; Ahluwalia A
Eur Heart J; 2024 May; 45(18):1647-1658. PubMed ID: 38513060
[TBL] [Abstract][Full Text] [Related]
24. Prevention of post-contrast kidney injury in patients with cancer.
Grassedonio E; Incorvaia L; Guarneri M; Guagnini F; Midiri M
Drugs Context; 2024; 13():. PubMed ID: 38510312
[TBL] [Abstract][Full Text] [Related]
25. Contrast-associated acute kidney injury and cardiovascular events: a secondary analysis of the PRESERVE cohort.
Murugan R; Boudreaux-Kelly MY; Kellum JA; Palevsky PM; Weisbord S
Clin Kidney J; 2023 Dec; 16(12):2626-2638. PubMed ID: 38046040
[TBL] [Abstract][Full Text] [Related]
26. Pharmacist-led iodinated contrast media infusion risk assessment service.
Jiang H; Li Y; Wu X; Yu H; Zhang X; Ge W; Yan S
Front Pharmacol; 2023; 14():1161621. PubMed ID: 37229268
[No Abstract] [Full Text] [Related]
27. Clinical significance of plasma PD-L1
Xu P; Liu J; Chen H; Shang L; Wang F; Zhu Y; Guo Y; Li F; Yan F; Xie X; Li L; Gu W; Lin Y
Ann Hematol; 2023 Sep; 102(9):2435-2444. PubMed ID: 37162517
[TBL] [Abstract][Full Text] [Related]
28. Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial.
Suárez Carantoña C; Escobar Cervantes C; Fabregate M; López Rodríguez M; Bara Ledesma N; Soto Pérez-Olivares J; Ruiz Ortega RA; López Castellanos G; Olavarría Delgado A; Blázquez Sánchez J; Gómez Del Olmo V; Moralejo Martín M; Pumares Álvarez MB; Sánchez Gallego MC; Llàcer P; Liaño F; Manzano L
J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109303
[TBL] [Abstract][Full Text] [Related]
29. Atherosclerotic plaque composition and specific endovascular considerations in the end stage renal disease patients: a narrative review.
Ruff C; Artzner C; Nikoalou K; Grözinger G
Cardiovasc Diagn Ther; 2023 Feb; 13(1):133-146. PubMed ID: 36864951
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the Abdominal Aorta and External Iliac Arteries Using Three-Dimensional Time-of-Flight, Three Dimensional Electrocardiograph-Gated Fast Spin-Echo, and Contrast-Enhanced Magnetic Resonance Angiography in Clinically Healthy Cats.
Lee M; Ko M; Ahn J; Ahn J; Yu J; Chang J; Oh S; Chang D
Front Vet Sci; 2022; 9():819627. PubMed ID: 35782562
[TBL] [Abstract][Full Text] [Related]
31. The Incidence and Associated Risk Factors of Contrast-Induced Nephropathy after Contrast-Enhanced Computed Tomography in the Emergency Setting: A Systematic Review.
Ong MY; Koh JJ; Kothan S; Lai C
Life (Basel); 2022 Jun; 12(6):. PubMed ID: 35743857
[TBL] [Abstract][Full Text] [Related]
32. Survival and recovery modeling of acute kidney injury in critically ill adults.
Brothers TN; Strock J; LeMasters TJ; Pawasauskas J; Reed RC; Al-Mamun MA
SAGE Open Med; 2022; 10():20503121221099359. PubMed ID: 35652035
[TBL] [Abstract][Full Text] [Related]
33. Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges.
Menè P; Stoppacciaro A; Lai S; Festuccia F
Int J Nephrol Renovasc Dis; 2022; 15():173-183. PubMed ID: 35592304
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2-intra-arterial administration.
van der Molen AJ; Dekkers IA; Bedioune I; Darmon-Kern E
Eur Radiol; 2022 Aug; 32(8):5546-5558. PubMed ID: 35312791
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol in more than 57,000 patients: part 1-intravenous administration.
van der Molen AJ; Dekkers IA; Bedioune I; Darmon-Kern E
Eur Radiol; 2022 Aug; 32(8):5532-5545. PubMed ID: 35312790
[TBL] [Abstract][Full Text] [Related]
36. The Pathophysiology and the Management of Radiocontrast-Induced Nephropathy.
Cho E; Ko GJ
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054347
[TBL] [Abstract][Full Text] [Related]
37. Negative effects of iodine-based contrast agent on renal function in patients with moderate reduced renal function hospitalized for COVID-19.
Kistner A; Tamm C; Svensson AM; Beckman MO; Strand F; Sköld M; Nyrén S
BMC Nephrol; 2021 Aug; 22(1):297. PubMed ID: 34465289
[TBL] [Abstract][Full Text] [Related]
38. The Application of Functional Magnetic Resonance Imaging in Type 2 Diabetes Rats With Contrast-Induced Acute Kidney Injury and the Associated Innate Immune Response.
Li Y; Shi D; Zhang H; Yao X; Wang S; Wang R; Ren K
Front Physiol; 2021; 12():669581. PubMed ID: 34267672
[TBL] [Abstract][Full Text] [Related]
39. Post-Contrast Acute Kidney Injury in Patients with Various Stages of Chronic Kidney Disease-Is Fear Justified?
Chomicka I; Kwiatkowska M; Lesniak A; Malyszko J
Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34206100
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the association between emergency dialysis start in patients with end-stage kidney disease and non-steroidal anti-inflammatory drugs, proton-pump inhibitors, and iodinated contrast agents.
Pétureau A; Raffray M; Polard E; Couchoud C; Vigneau C; Bayat S
J Nephrol; 2021 Oct; 34(5):1711-1723. PubMed ID: 33877637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
